85. It would be appropriate to report a medication error in the event that a pharmacy substituted:

Answer: C

Explanation:

Reporting a medication error is appropriate when a pharmacy substitutes Clonidine for Klonopin.

Substituting Clonidine for Klonopin represents a serious medication error due to the significant differences in their pharmacological effects and indications. Klonopin (clonazepam) is a benzodiazepine used primarily for anxiety and seizure disorders, while Clonidine is an antihypertensive medication used to treat high blood pressure and ADHD.

A) Celecoxib for Celebrex

This substitution is not a medication error, as Celecoxib is the generic name for Celebrex. Therefore, substituting the brand name for its generic equivalent is appropriate and does not constitute an error.

B) Bumetanide for Bumex

Bumetanide is the generic name for Bumex, making this substitution acceptable. Since both names refer to the same medication, this action does not represent a medication error.

C) Clonidine for Klonopin

This is a critical error because Clonidine and Klonopin have vastly different uses and mechanisms of action. Administering Clonidine instead of Klonopin could lead to severe adverse effects and ineffective treatment of the patient's condition, making it imperative to report.

D) Valacyclovir for Valtrex

Valacyclovir is the generic name for Valtrex, and substituting one for the other is completely appropriate. There is no error in this case, as both refer to the same antiviral medication.

Conclusion

The substitution of Clonidine for Klonopin is a significant medication error due to the differing pharmacological properties and therapeutic indications of the two drugs. In contrast, the other options involve substitutions between brand and generic names, which are medically acceptable and do not represent errors. Reporting this error is crucial for patient safety and effective medication management.